OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 122 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $179,000 | -83.9% | 525 | -86.8% | 0.01% | -79.2% |
| Q4 2015 | $1,114,000 | -8.3% | 3,966 | -17.3% | 0.02% | -17.2% |
| Q3 2015 | $1,215,000 | +192.1% | 4,794 | -3.3% | 0.03% | +222.2% |
| Q2 2015 | $416,000 | +123.7% | 4,956 | -14.8% | 0.01% | +200.0% |
| Q1 2015 | $186,000 | -50.0% | 5,815 | -56.1% | 0.00% | -57.1% |
| Q4 2014 | $372,000 | -60.7% | 13,247 | -84.3% | 0.01% | -65.0% |
| Q3 2014 | $946,000 | +1450.8% | 84,219 | +5140.8% | 0.02% | +1900.0% |
| Q2 2014 | $61,000 | +238.9% | 1,607 | +318.5% | 0.00% | – |
| Q1 2014 | $18,000 | – | 384 | +1820.0% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 20 | -99.9% | 0.00% | -100.0% |
| Q3 2013 | $181,000 | -10.0% | 26,720 | -0.7% | 0.00% | -20.0% |
| Q2 2013 | $201,000 | – | 26,920 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |